A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
Ben-Josef, Edgar, MD, Schipper, Mathew, PhD, Francis, Isaac R., MD, Hadley, Scott, PhD, Ten-Haken, Randall, PhD, Lawrence, Theodore, MD, PhD, Normolle, Daniel, PhD, Simeone, Diane M., MD, Sonnenday, Christopher, MD, Abrams, Ross, MD, Leslie, William, MD, Khan, Gazala, MD, Zalupski, Mark M., MD
Published in International journal of radiation oncology, biology, physics (01.12.2012)
Published in International journal of radiation oncology, biology, physics (01.12.2012)
Get full text
Journal Article
Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study
Vainshtein, Jeffrey M., MD, Schipper, Matthew, PhD, Zalupski, Mark M., MD, Lawrence, Theodore S., MD, PhD, Abrams, Ross, MD, Francis, Isaac R., MD, Khan, Gazala, MD, Leslie, William, MD, Ben-Josef, Edgar, MD
Published in International journal of radiation oncology, biology, physics (01.05.2013)
Published in International journal of radiation oncology, biology, physics (01.05.2013)
Get full text
Journal Article
New frontiers in pancreatic cancer research
Khan, Gazala N, di Magliano, Marina Pasca, Simeone, Diane M
Published in Surgical oncology clinics of North America (01.04.2010)
Published in Surgical oncology clinics of North America (01.04.2010)
Get more information
Journal Article